Login / Signup
Identification of MTHFD2 as a prognostic biomarker and ferroptosis regulator in triple-negative breast cancer.
Hao Zhang
Shuangli Zhu
Haiting Zhou
Rui Li
Xiaohui Xia
Huihua Xiong
Published in:
Frontiers in oncology (2023)
MTHFD2 could be a crucial molecular biomarker for predicting patient prognosis and a novel therapeutic target in TNBC. In addition, MTHFD2 is a potential ferroptosis regulatory gene in TNBC.
Keyphrases
</>
cell death
transcription factor
copy number
genome wide
genome wide identification
dna methylation
single molecule
bioinformatics analysis
genome wide analysis